Sex differences in COVID-19 course and outcome: progesterone should not be neglected.

Jakovac, Hrvoje

Jakovac, Hrvoje.

Jakovac H; Department of Physiology and Immunology, Medical Faculty, University of Rijeka, Rijeka, Croatia.

J Appl Physiol (1985) ; 129(5): 1007-1008, 2020 11 01.

Article in English | MEDLINE | ID: covidwho-887453

Subject(s)

Betacoronavirus; Coronavirus Infections/blood; Disease Progression; Pneumonia, Viral/blood; Progesterone/blood; Sex Characteristics; COVID-19; Coronavirus Infections/immunology; Coronavirus Infections/therapy; Female; Humans; Male; Pandemics; Pneumonia, Viral/immunology; Pneumonia, Viral/therapy; Progesterone/immunology; SARS-CoV-2; Treatment Outcome

Keywords

COVID-19; SARS-CoV-2; progesterone; severity; sex differences

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Progesterone / Sex Characteristics / Coronavirus Infections / Disease Progression / Betacoronavirus Type of study: Prognostic study Limits: Female / Humans / Male Language: English Journal: J Appl Physiol (1985) Journal subject: Physiology Year: 2020 Document Type: Article Affiliation country: Japplphysiol.00740.2020

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google